Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice

Author:

Volta Mattia1ORCID,Beccano-Kelly Dayne A1ORCID,Paschall Sarah A12ORCID,Cataldi Stefano12ORCID,MacIsaac Sarah E12,Kuhlmann Naila123,Kadgien Chelsie A123,Tatarnikov Igor1,Fox Jesse1,Khinda Jaskaran1,Mitchell Emma1,Bergeron Sabrina1,Melrose Heather4,Farrer Matthew J1,Milnerwood Austen J13ORCID

Affiliation:

1. Centre for Applied Neurogenetics, University of British Columbia, Vancouver, Canada

2. Graduate Program in Neurosciences, University of British Columbia, Vancouver, Canada

3. Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Canada

4. Mayo Clinic, Jacksonville, United States

Abstract

LRRK2 mutations produce end-stage Parkinson’s disease (PD) with reduced nigrostriatal dopamine, whereas, asymptomatic carriers have increased dopamine turnover and altered brain connectivity. LRRK2 pathophysiology remains unclear, but reduced dopamine and mitochondrial abnormalities occur in aged G2019S mutant knock-in (GKI) mice. Conversely, cultured GKI neurons exhibit increased synaptic transmission. We assessed behavior and synaptic glutamate and dopamine function across a range of ages. Young GKI mice exhibit more vertical exploration, elevated glutamate and dopamine transmission, and aberrant D2-receptor responses. These phenomena decline with age, but are stable in littermates. In young GKI mice, dopamine transients are slower, independent of dopamine transporter (DAT), increasing the lifetime of extracellular dopamine. Slowing of dopamine transients is observed with age in littermates, suggesting premature ageing of dopamine synapses in GKI mice. Thus, GKI mice exhibit early, but declining, synaptic and behavioral phenotypes, making them amenable to investigation of early pathophysiological, and later parkinsonian-like, alterations. This model will prove valuable in efforts to develop neuroprotection for PD.

Funder

Michael J. Fox Foundation for Parkinson's Research

Parkinson Canada

Canadian Institutes of Health Research

Canada Excellence Research Chairs, Government of Canada

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3